Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q4 FY26 results · Jan–Mar 2026
Wockhardt reported revenue from operations of ₹965.00 crore (up 29.9% from Q4 FY25) and net profit of ₹164.00 crore for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 965.00 | 743.00 | +29.9% | 888.00 | +8.7% |
| Other income | 45.00 | 15.00 | +200.0% | 25.00 | +80.0% |
| Total income | 1,010.00 | 758.00 | +33.2% | 913.00 | +10.6% |
| Profit before tax | 189.00 | (22.00) | Turned profit | 67.00 | +182.1% |
| Net profit for the period | 164.00 | (45.00) | Turned profit | 61.00 | +168.9% |
| Attributable to shareholders of the company | 166.00 | (25.00) | Turned profit | 59.00 | +181.4% |
| EPS, basic (₹) | 10.23 | (1.57) | Turned profit | 3.61 | +183.4% |
| Net margin (%) | 17.0 | -6.1 | 6.9 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 516.00 | 355.00 | +45.4% | 430.00 | +20.0% |
| Other income | 55.00 | 14.00 | +292.9% | 27.00 | +103.7% |
| Total income | 571.00 | 369.00 | +54.7% | 457.00 | +24.9% |
| Profit before tax | 167.00 | 40.00 | +317.5% | 28.00 | +496.4% |
| Net profit for the period | 167.00 | 40.00 | +317.5% | 28.00 | +496.4% |
| EPS, basic (₹) | 10.29 | 2.47 | +316.6% | 1.73 | +494.8% |
| Net margin (%) | 32.4 | 11.3 | 6.5 |
Consolidated
- Filed with BSE
- 04 May 2026, 19:28 IST
- Board meeting
- 04 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 May 2026, 19:28 IST
- Board meeting
- 04 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE